TABLE 1.
Demographics and clinical characteristics of patients taking 81 mg of aspirin daily and controls
| Characteristics | Control not taking aspirin (n = 10) | Patients taking 81 mg of aspirin daily (n = 150) |
|---|---|---|
| Mean (SD) | ||
| Age, y | 50.4 (25) | 69 (12) |
| Platelet count, 103/μL | 178 (23) | 222 (68) |
| Leukocyte count, 103/μL | 5.7 (2) | 7.4 (2) |
| Hematocrit | 37.1 (2) | 39.2 (4) |
| Frequency (%) | ||
| Sex, male | 4 (40) | 96 (64) |
| Hypertension | 2 (20) | 105 (70) |
| Hypercholesterolemia | 1 (10) | 119 (79) |
| Diabetes | 0 (0) | 58 (39) |
| Smoking history | 5 (50) | 114 (76) |
| CAS | 0 (0) | 35 (23) |
| PAD | 0 (0) | 119 (79) |
| CAD | 0 (0) | 45 (30) |
| Stroke | 0 (0) | 18 (12) |
| Statin | 1 (10) | 18 (12) |
| ACEi/ARB | 1 (10) | 79 (53) |
| Beta blocker | 1 (10) | 42 (28) |
| Calcium channel blocker | 1 (10) | 32 (21) |
Continuous variables are showing by mean (standard deviation), and categorical variables are shown in number (percent).
Abbreviations: ACEi, angiotensin‐converting enzyme (ACE) inhibitor; ARB, angiotensin receptor blocker; CAD, coronary artery disease; CAS, carotid artery stenosis; PAD, peripheral arterial disease.